Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sabin IPV (Vero cell) + bOPV 2+1 sequential schedule in infants
CTR20180599Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Sabin Inactivated Poliovirus Vaccine (Vero Cell) in poliomyelitis, sponsored by Sinovac Biotech Ltd.. Started May 2018; status: completed.
02
Drugs
Sabin Inactivated Poliovirus Vaccine (Vero Cell)
03
Conditions
poliomyelitis
Beyond the preview
Go deeper on CTR20180599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180599.